Market Place
Sourcing Support
All News #Library
Biotech
Hummingbird Bioscience Initiates Phase I Trial For HMBD-501
06 Jan 2026 //
GLOBENEWSWIRE
Hummingbird Licenses Anti-VISTA Antibody HMBD-002 to Percheron
25 Jun 2025 //
GLOBENEWSWIRE
Hummingbird Bioscience Licenses Novel Antibodies to Immunome
07 Jan 2025 //
GLOBENEWSWIRE
Hummingbird Bioscience Presents HMBD-802 at EORTC-NCI-AACR
23 Oct 2024 //
GLOBENEWSWIRE
Hummingbird Presents Next-Gen ADC Data At PEGS Boston 2024
13 May 2024 //
GLOBENEWSWIRE
Hummingbird Bioscience Announces Positive Phase I Clinical Data for HMBD-001
23 Oct 2023 //
PR NEWSWIRE
Endeavor signs $430M deal for Hummingbird’s HER3-targeted ADC
20 Oct 2023 //
FIERCE BIOTECH
Hummingbird Bioscience and Merck Enter Collaboration to Evaluate HMBD-001
15 May 2023 //
PR NEWSWIRE
Hummingbird Exercises Its Option to License Trial Results to Support HMBD-001
06 Mar 2023 //
PR NEWSWIRE
Hummingbird Bio buzzes Synaffix for $150M ADC licensing deal
05 Jan 2023 //
FIERCE BIOTECH
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.